Goey, K K H <br/><br/>
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 2017 
 - 2128-2134 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx322  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab--administration & dosage<br/>Brain Neoplasms--genetics<br/>Capecitabine--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>DNA Mismatch Repair--genetics<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neoplasm Metastasis<br/>Neoplastic Syndromes, Hereditary--genetics<br/>Observation<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Treatment Outcome<br/>ras Proteins--genetics